Insulet Reports Fourth Quarter Revenue of $130.5 Million, Up 26%, and Gross Margin Up 210 Basis Points, Exceeding Expectations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Insulet Corporation (PODD) PT Raised to $90 at Cowen; Beat and Raise
February 22, 2018 6:55 AM ESTCowen raised its price target on Insulet Corporation (NASDAQ: PODD) to $90.00 (from $80.00) while maintaining a Outperform rating.
Analyst Doug Schenkel commented, "PODD posted another strong beat and initiated 2018 guidance well ahead of expectations at the top and bottom lines, despite lighter than expected... More
Insulet (PODD) Misses Q4 EPS by 4c, Revs Beat
February 21, 2018 4:01 PM ESTInsulet (NASDAQ: PODD) reported Q4 EPS of ($0.12), $0.04 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $130.5 million versus the consensus estimate of $125.15 million.
For earnings history and earnings-related data on Insulet (PODD) click here.
... More